Publications Database

de Vries M. et al. (2015)

Working memory and cognitive flexibility-training for children with an autism spectrum disorder: a randomized controlled trial.

Journal of Child Psychology and Psychiatry

May, 56(5), pp. 566-576.

Read Abstract (New Window)

Walters A. S. et al. (1990)

A case report of naltrexone treatment of self-injury and social withdrawal in autism.

Journal of Autism and Developmental Disorders

20(2), pp. 169-176

Read Extract (New Window)

Wasdell M. B. et al. (2007)

A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities.

Journal of Pineal Research

44(1), pp. 57-64

Read Abstract (New Window)

Wasserman S. et al. (2006)

Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study.

International Clinical Psychopharmacology

21(6), pp. 363-367

Read Abstract (New Window)

Watanabe T. et al. (2015)

Clinical and neural effects of six-week administration of oxytocin on core symptoms of autism.

Brain

November, 138(11), pp. 3400-3412.

Read Abstract (New Window)

Watanabe T. et al. (2014)

Mitigation of sociocommunicational deficits of autism through oxytocin-induced recovery of medial prefrontal activity: A randomized trial.

Journal of the American Medical Association

February, 71(2), pp. 166-175.

Read Abstract (New Window)

Wilkins A. J. et al. (1994)

Double-masked placebo controlled trial of precision spectral filters in children who use coloured overlays.

Ophthalmic and Physiological Optics

14(4), pp. 365-370

Read Abstract (New Window)

Willemsen-Swinkels S. H. et al. (1995)

Failure of naltrexone hydrochloride to reduce self-injurious and autistic behaviour in mentally retarded adults: double-blinded placebo-controlled studies.

Archives of General Psychiatry

52(9), pp. 766-773

Read Abstract (New Window)

Willemsen-Swinkels S. H. et al. (1995)

Placebo-controlled acute dosage naltrexone study in young autistic children.

Psychiatry Research

58(3), pp. 203-215

Read Abstract (New Window)

Willemsen-Swinkels S. H. , Buitelaar J. K. , van Engeland H. (1996)

The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study.

Biological Psychiatry

39(12), pp. 1023-1031

Read Abstract (New Window)

Wink L. K. et al.

A randomized placebo-controlled cross-over pilot study of riluzole for drug-refractory irritability in autism spectrum disorder.

Journal of Autism and Developmental Disorders

Read Abstract (New Window)

Wink L. K. et al. (2016)

A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder.

Molecular Autism

7(26),

Read Full (New Window)

Wink L. K. et al. (2017)

d-Cycloserine enhances durability of social skills training in autism spectrum disorder.

Molecular Autism

Read Abstract (New Window) Read Full (New Window)

Wirojanan J. et al. (2009)

The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome, or autism and fragile X syndrome.

Journal of Clinical Sleep Medicine

5(2), pp. 145-150

Read Abstract (New Window) Read Full (New Window)

Wong V. C. , Chen W. (2010)

Randomized controlled trial of electro-acupuncture for autism spectrum disorder.

Alternative Medicine Review

15(2), pp. 136-146

Read Abstract (New Window)

Woodard C. R. et al. (2007)

A placebo double-blind pilot study of dextromethorphan for problematic behaviors in children with autism.

Autism

11(1), pp. 29-41

Read Abstract (New Window)

Wright B. et al. (2011)

Melatonin versus placebo in children with autism spectrum conditions and severe sleep problems not amenable to behaviour management strategies: A randomised controlled crossover trial.

Journal of Autism and Developmental Disorders

February, 41(2), pp. 175-184.

Read Abstract (New Window)

Yarbrough E. et al. (1987)

Effects of fenfluramine on autistic individuals residing in a state developmental center.

Journal of Autism and Developmental Disorders

17(3), pp. 303-314

Read Abstract (New Window)

Yatawara C. et al. (2015)

The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial.

Molecular Psychiatry

pp. 1-7.

Read Full (New Window)

Yui K. et al. (2012)

Effects of large doses of arachidonic acid added to docosahexaenoic acid on social impairment in individuals with autism spectrum disorders: a double-blind, placebo-controlled, randomized trial.

Journal of Clinical Psychopharmacology

32(2), pp. 200-206.

Read Abstract (New Window)